Dipyridamole description: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
{| | {| | ||
|- | |- | ||
|[[File:Dipyriamole01.gif|thumb| | |[[File:Dipyriamole01.gif|thumb|1200px]] | ||
|- | |- | ||
|} | |} | ||
| Line 13: | Line 13: | ||
{| | {| | ||
|- | |- | ||
|[[File: | |[[File:Dipyriamole03.jpg|thumb|800px]] | ||
|- | |- | ||
|} | |} | ||
Revision as of 02:58, 7 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Description
PERSANTINE® (dipyridamole USP) is a platelet inhibitor chemically described as 2,2',2",2"'-[(4,8- Dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]-tetraethanol. It has the following structural formula:
 |
 |
Dipyridamole is an odorless yellow crystalline powder, having a bitter taste. It is soluble in dilute acids, methanol and chloroform, and practically insoluble in water.
PERSANTINE tablets for oral administration contain:
Active IngredientTABLETS 25 mg, 50 mg, and 75 mg: dipyridamole USP 25 mg , 50 mg and 75 mg, respectively.
Inactive IngredientsTABLETS 25 mg, 50 mg, and 75 mg: acacia, carnauba wax, corn starch, edible white ink, lactose monohydrate, magnesium stearate, D&C yellow #10 aluminum lake, D&C red #30, helendon aluminum pink lake, sodium benzoate, methylparaben, propylparaben, polyethylene glycol, povidone, sucrose, talc, titanium dioxide, and white wax.[1]
References
- ↑ "PERSANTINE (DIPYRIDAMOLE) TABLET, COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]". Retrieved 7 February 2014.